v3.25.2
Acquisitions, Dispositions, and Funded Research and Development Arrangements - Disposal Activity (Details) - USD ($)
$ in Millions
12 Months Ended
Feb. 20, 2024
Apr. 01, 2023
Apr. 25, 2025
Apr. 26, 2024
Apr. 28, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Impairment of finite-lived intangible assets     $ 0   $ 0
Contingent consideration receivable       $ 58  
Noncontrolling interests     232 206  
Asset impairments and related inventory write-downs     $ 0 371 0
Mozarc          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Ownership percentage   50.00% 50.00%    
Mozarc          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Noncontrolling interests   $ 307      
Renal Care Solutions | Other operating (income) expense, net          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Asset impairments and related inventory write-downs         $ 136
Renal Care Solutions | Mozarc | Maximum          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Contingent consideration receivable   300      
Disposal Group, Not Discontinued Operations | Ventilator Product Line Exit          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Business exit costs $ 439        
Discontinued operation, other operating expense, net 369        
Cost of products sold, excluding amortization of intangible assets 70        
Non-cash impairments 371        
Impairment of finite-lived intangible assets       $ 295  
Inventory write-down $ 70        
Disposal Group, Not Discontinued Operations | Renal Care Solutions | Mozarc          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Proceeds from sale of businesses   45      
Contingent consideration receivable   195      
Payments to acquire long-term investments   $ 224